Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study

MİRİLİ, CEM; Payday, Semra; GÜNEY, İSA; OĞUL, ALİ; GÖKÇAY, SERKAN; BÜYÜKŞİMŞEK, MAHMUT; YETİŞİR, ABDULLAH; Karaalioglu, Bilgin; TOHUMCUOĞLU, MERT; SEYDAOĞLU, GÜLŞAH

doi:10.2147/cmar.s191199

Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study

Atıf İçin Kopyala

MİRİLİ C. , Payday S., GÜNEY İ. B. , OĞUL A. , GÖKÇAY S. , BÜYÜKŞİMŞEK M. , et al.

CANCER MANAGEMENT AND RESEARCH, cilt.11, ss.3445-3453, 2019 (SCI İndekslerine Giren Dergi)

Cilt numarası: 11
Basım Tarihi: 2019
Doi Numarası: 10.2147/cmar.s191199
Dergi Adı: CANCER MANAGEMENT AND RESEARCH
Sayfa Sayısı: ss.3445-3453

Özet

Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.